Neurontin · DIN 02084260 · 100 mg · capsule
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Neurontin · DIN 02084260
Manufacturer: Upjohn Canada ULC; listing date 1996-10-01
Health Canada: Marketed since 2023-05-05 · brand NEURONTIN · ATC N02BF01 GABAPENTIN · form Capsule · route Oral · ingredients GABAPENTIN 100 MG · company Bgp pharma ulc · schedule Prescription
Ministry pays: $0.0416 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02084260)
Source record
DIN 02084260: Neurontin
Raw flags: sec3=Y
Item: 281200062; group id 430; item number 1070; lccId None; manufacturer id UJC
Source form: Cap; strength: 100mg
Recorded listing: General benefit
Source prices (unrounded): $0.5615; ministry $0.0416
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02084260
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=15944
Interchangeable products
AG-Gabapentin · DIN 02477912 · $0.0416
Apo-Gabapentin · DIN 02244304 · $0.0416
Auro-Gabapentin · DIN 02321203 · $0.0416
Co Gabapentin · DIN 02256142 · $0.0416
Gabapentin · DIN 02246314 · $0.0416
Gabapentin · DIN 02353245 · $0.0416
Gabapentin Capsules USP · DIN 02416840 · $0.0416
Jamp Gabapentin Capsules · DIN 02535246 · $0.0416
Jamp-Gabapentin · DIN 02361469 · $0.0416
Mar-Gabapentin · DIN 02391473 · $0.0416
Mint-Gabapentin · DIN 02408880 · $0.0416
NRA-Gabapentin · DIN 02550016 · $0.0416
PMS-Gabapentin · DIN 02243446 · $0.0416
Ran-Gabapentin · DIN 02319055 · $0.0416
Teva-Gabapentin · DIN 02244513 · $0.0416
Shortage status: resolved shortage (ended July 19, 2023); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02084260
Shortage record checked October 6, 2026